Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial‐to‐mesenchymal transition via miR‐424 …
C Cui, N Zang, J Song, X Guo, Q He, H Hu… - The FASEB …, 2022 - Wiley Online Library
Diabetic kidney disease (DKD) is well‐acknowledged as one of the most common
complications in diabetes mellitus. Recent studies have demonstrated the promising role of …
complications in diabetes mellitus. Recent studies have demonstrated the promising role of …
Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to-mesenchymal transition via miR-424 …
C Cui, N Zang, J Song, X Guo, Q He… - … publication of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Diabetic kidney disease (DKD) is well-acknowledged as one of the most common
complications in diabetes mellitus. Recent studies have demonstrated the promising role of …
complications in diabetes mellitus. Recent studies have demonstrated the promising role of …
Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to-mesenchymal transition via miR-424 …
C Cui, N Zang, J Song, X Guo, Q He, H Hu… - … : Official Publication of …, 2022 - europepmc.org
Diabetic kidney disease (DKD) is well-acknowledged as one of the most common
complications in diabetes mellitus. Recent studies have demonstrated the promising role of …
complications in diabetes mellitus. Recent studies have demonstrated the promising role of …